Diagnostic Refinement and Educational Approaches in Managing Bone Marrow Transplantation

Recruiting now · Not applicable

Conditions studied: GVHD, Bone Marrow Transplant Complications

In brief

This randomized, phase I/II, open-label study will investigate the efficacy and safety of an educational sleep intervention vs standard of care in adults undergoing alloHSCT. The randomization target in this pilot phase is 60 patients.

Key facts

Study ID

NCT06590285

Run by

Scripps Health

People needed

60

Starts

2026-04-02

Expected to finish

2033-11-01

Last updated by the study team

2026-04-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female patients aged 18 or older at the time of study informed consent.
• Have plan to undergo alloHSCT from any donor source using bone marrow, peripheral blood stem cells, or cord blood. Recipients of non-myeloablative, myeloablative and reduced intensity conditioning are eligible.
• Patients have access to digital device capable of downloading study app
• Patients able to read study documents and able to complete informed consent within the study app

You may not qualify if…

• Failed prior alloHSCT within the past 6 months

Where it is running

• Scripps Health — San Diego, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.